332 related articles for article (PubMed ID: 31602695)
1. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial.
Kashani L; Esalatmanesh S; Eftekhari F; Salimi S; Foroughifar T; Etesam F; Safiaghdam H; Moazen-Zadeh E; Akhondzadeh S
Arch Gynecol Obstet; 2018 Mar; 297(3):717-724. PubMed ID: 29332222
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression.
Tabeshpour J; Sobhani F; Sadjadi SA; Hosseinzadeh H; Mohajeri SA; Rajabi O; Taherzadeh Z; Eslami S
Phytomedicine; 2017 Dec; 36():145-152. PubMed ID: 29157808
[TBL] [Abstract][Full Text] [Related]
4. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
[TBL] [Abstract][Full Text] [Related]
5. The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial.
Milajerdi A; Jazayeri S; Shirzadi E; Hashemzadeh N; Azizgol A; Djazayery A; Esmaillzadeh A; Akhondzadeh S
Complement Ther Med; 2018 Dec; 41():196-202. PubMed ID: 30477839
[TBL] [Abstract][Full Text] [Related]
6. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
[TBL] [Abstract][Full Text] [Related]
7. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.
Modabbernia A; Sohrabi H; Nasehi AA; Raisi F; Saroukhani S; Jamshidi A; Tabrizi M; Ashrafi M; Akhondzadeh S
Psychopharmacology (Berl); 2012 Oct; 223(4):381-8. PubMed ID: 22552758
[TBL] [Abstract][Full Text] [Related]
8. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial.
Moazen-Zadeh E; Abbasi SH; Safi-Aghdam H; Shahmansouri N; Arjmandi-Beglar A; Hajhosseinn Talasaz A; Salehiomran A; Forghani S; Akhondzadeh S
J Altern Complement Med; 2018 Apr; 24(4):361-368. PubMed ID: 29185780
[TBL] [Abstract][Full Text] [Related]
9. Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.
Ahmadpanah M; Ramezanshams F; Ghaleiha A; Akhondzadeh S; Sadeghi Bahmani D; Brand S
Psychiatry Res; 2019 Dec; 282():112613. PubMed ID: 31669837
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression.
Mazidi M; Shemshian M; Mousavi SH; Norouzy A; Kermani T; Moghiman T; Sadeghi A; Mokhber N; Ghayour-Mobarhan M; Ferns GA
J Complement Integr Med; 2016 Jun; 13(2):195-9. PubMed ID: 27101556
[TBL] [Abstract][Full Text] [Related]
11. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S
BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889
[TBL] [Abstract][Full Text] [Related]
12. Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial.
Ghajar A; Neishabouri SM; Velayati N; Jahangard L; Matinnia N; Haghighi M; Ghaleiha A; Afarideh M; Salimi S; Meysamie A; Akhondzadeh S
Pharmacopsychiatry; 2017 Jul; 50(4):152-160. PubMed ID: 27701683
[No Abstract] [Full Text] [Related]
13. affron
Kell G; Rao A; Beccaria G; Clayton P; Inarejos-García AM; Prodanov M
Complement Ther Med; 2017 Aug; 33():58-64. PubMed ID: 28735826
[TBL] [Abstract][Full Text] [Related]
14. Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial.
Karimi-Nazari E; Nadjarzadeh A; Masoumi R; Marzban A; Mohajeri SA; Ramezani-Jolfaie N; Salehi-Abargouei A
Clin Nutr ESPEN; 2019 Dec; 34():130-136. PubMed ID: 31677703
[TBL] [Abstract][Full Text] [Related]
15. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.
Moshiri E; Basti AA; Noorbala AA; Jamshidi AH; Hesameddin Abbasi S; Akhondzadeh S
Phytomedicine; 2006 Nov; 13(9-10):607-11. PubMed ID: 16979327
[TBL] [Abstract][Full Text] [Related]
16. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.
Akhondzadeh S; Shafiee Sabet M; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SS; Yousefi MH; Alimardani R; Jamshidi A; Rezazadeh SA; Yousefi A; Zare F; Moradi A; Vossoughi A
Psychopharmacology (Berl); 2010 Jan; 207(4):637-43. PubMed ID: 19838862
[TBL] [Abstract][Full Text] [Related]
17. affron
Lopresti AL; Drummond PD; Inarejos-García AM; Prodanov M
J Affect Disord; 2018 May; 232():349-357. PubMed ID: 29510352
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
Shahmansouri N; Farokhnia M; Abbasi SH; Kassaian SE; Noorbala Tafti AA; Gougol A; Yekehtaz H; Forghani S; Mahmoodian M; Saroukhani S; Arjmandi-Beglar A; Akhondzadeh S
J Affect Disord; 2014 Feb; 155():216-22. PubMed ID: 24289892
[TBL] [Abstract][Full Text] [Related]
19. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
Hausenblas HA; Saha D; Dubyak PJ; Anton SD
J Integr Med; 2013 Nov; 11(6):377-83. PubMed ID: 24299602
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].
Akhondzadeh S; Fallah-Pour H; Afkham K; Jamshidi AH; Khalighi-Cigaroudi F
BMC Complement Altern Med; 2004 Sep; 4():12. PubMed ID: 15341662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
